136 related articles for article (PubMed ID: 10793610)
1. Safe use of remifentanil in a patient treated with the monoamine oxidase inhibitor phenelzine.
Ure DS; Gillies MA; James KS
Br J Anaesth; 2000 Mar; 84(3):414-6. PubMed ID: 10793610
[TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase inhibitors revisited.
Wells DG; Bjorksten AR
Can J Anaesth; 1989 Jan; 36(1):64-74. PubMed ID: 2563341
[No Abstract] [Full Text] [Related]
3. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
Celada P; Pérez J; Alvarez E; Artigas F
J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine.
Baker G; Matveychuk D; MacKenzie EM; Holt A; Wang Y; Kar S
Chem Biol Interact; 2019 May; 304():139-147. PubMed ID: 30857888
[TBL] [Abstract][Full Text] [Related]
5. [Clinical case of the month. Mental confusion due to the administration of tramadol in a patient treated with MOAI].
Calvisi V; Ansseau M
Rev Med Liege; 1999 Dec; 54(12):912-3. PubMed ID: 10686795
[TBL] [Abstract][Full Text] [Related]
6. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
[TBL] [Abstract][Full Text] [Related]
8. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
Baker GB; Sowa B; Todd KG
J Psychiatry Neurosci; 2007 Sep; 32(5):313-5. PubMed ID: 17823646
[No Abstract] [Full Text] [Related]
9. Antidepressant phenelzine alters differentiation of cultured human and mouse preadipocytes.
Chiche F; Le Guillou M; Chétrite G; Lasnier F; Dugail I; Carpéné C; Moldes M; Fève B
Mol Pharmacol; 2009 May; 75(5):1052-61. PubMed ID: 19201819
[TBL] [Abstract][Full Text] [Related]
10. Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzine.
Carpéné C; Mercader J; Le Gonidec S; Schaak S; Mialet-Perez J; Zakaroff-Girard A; Galitzky J
Br J Pharmacol; 2018 Jun; 175(12):2428-2440. PubMed ID: 29582416
[TBL] [Abstract][Full Text] [Related]
11. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.
Paslawski T; Treit D; Baker GB; George M; Coutts RT
Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939
[TBL] [Abstract][Full Text] [Related]
12. Interactions between catecholamines and tricyclic and monoamine oxidase inhibitor antidepressive agents in man.
Barar FS; Boakes AJ; Benedikter LB; Laurence DR; Prichard BN; Teoh PC
Br J Pharmacol; 1971 Oct; 43(2):472P-473P. PubMed ID: 5158242
[No Abstract] [Full Text] [Related]
13. Do monoamine oxidase inhibitors alter carbamazepine blood levels?
Barklage NE; Jefferson JW; Margolis D
J Clin Psychiatry; 1992 Jul; 53(7):258. PubMed ID: 1639748
[No Abstract] [Full Text] [Related]
14. The effect of some tricyclic antidepressants on the inhibition of mouse brain monoamine oxidase in-vivo by phenelzine.
Green AL; O'Grady JE; Vass M
J Pharm Pharmacol; 1989 Jan; 41(1):50-1. PubMed ID: 2565965
[TBL] [Abstract][Full Text] [Related]
15. The influence of some MAO inhibitors and neuroleptics on enzymes concerned in GABA metabolism.
Simánĕ Z; Kraus P
Act Nerv Super (Praha); 1968 Oct; 10(3):331. PubMed ID: 4387433
[No Abstract] [Full Text] [Related]
16. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
Wooters TE; Bardo MT
Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
[TBL] [Abstract][Full Text] [Related]
17. Anaphylaxis and monoamine oxidase inhibitors--the use of adrenaline.
Fenwick MJ; Muwanga CL
J Accid Emerg Med; 2000 Mar; 17(2):143-4. PubMed ID: 10718244
[TBL] [Abstract][Full Text] [Related]
18. Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.
Matveychuk D; MacKenzie EM; Kumpula D; Song MS; Holt A; Kar S; Todd KG; Wood PL; Baker GB
Cell Mol Neurobiol; 2022 Jan; 42(1):225-242. PubMed ID: 33839994
[TBL] [Abstract][Full Text] [Related]
19. MAOIs: still here, still dangerous.
Ahmed DS; Fecik S
Am J Nurs; 2000 Feb; 100(2):29-30. PubMed ID: 10683640
[No Abstract] [Full Text] [Related]
20. Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response.
Heydendael W; Jacobson L
Brain Res; 2008 Oct; 1238():93-107. PubMed ID: 18761333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
